

Publisher: John Wiley & Sons Inc
E-ISSN: 1472-8206|32|1|114-119
ISSN: 0767-3981
Source: Fundamental & Clinical Pharmacology, Vol.32, Iss.1, 2018-02, pp. : 114-119
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content








Risk of Antipsychotic Drug Use in Patients with Alzheimers Disease Treated with Rivastigmine
By Suh D-C.
Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. :